vTv Therapeutics Schedules Shareholder Vote
Ticker: VTVT · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1641489
| Field | Detail |
|---|---|
| Company | Vtv Therapeutics Inc. (VTVT) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: VTVT
TL;DR
vTvT shareholders are voting on something important.
AI Summary
On June 10, 2025, vTv Therapeutics Inc. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing does not specify the exact nature of the vote or any associated resolutions, but it indicates that a shareholder vote is scheduled or has occurred. The company, incorporated in Delaware, is based in High Point, NC.
Why It Matters
Shareholder votes can impact corporate governance, strategic decisions, and potentially the company's future direction.
Risk Assessment
Risk Level: medium — Shareholder votes can lead to significant changes in company strategy or leadership, introducing uncertainty.
Key Players & Entities
- vTv Therapeutics Inc. (company) — Registrant
- June 10, 2025 (date) — Date of earliest event reported
- High Point, NC (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What specific matters are being submitted to a vote of vTv Therapeutics Inc. security holders?
The filing states that matters are being submitted to a vote, but does not specify the exact nature of these matters or the resolutions being voted upon.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated June 10, 2025.
Where are vTv Therapeutics Inc.'s principal executive offices located?
The principal executive offices are located at 3980 Premier Drive, Suite 310, High Point, NC 27265.
In which state was vTv Therapeutics Inc. incorporated?
vTv Therapeutics Inc. was incorporated in Delaware.
What is the Nasdaq ticker symbol for vTv Therapeutics Inc.?
The filing indicates Nasdaq and the accession number 0001641489, but the specific ticker symbol is not explicitly stated in the provided text, though it is commonly known as VTVT.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding vTv Therapeutics Inc. (VTVT).